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Abstract
Background: Coinfection with malaria and HIV is common in Sub-Saharan Africa. In the advent of a decline in the
global incidence of malaria, it is important to generate updated data on the burden of malaria in people living with
HIV (PLWHIV). This study was designed to determine the prevalence of malaria in PLWHIV in Yaounde, Cameroon,
as well determine the association between CD4
+ T cell count and malaria in the study population.
Methods: In a cross sectional study performed between April 2015 and June 2016, 355 PLWHIV were enrolled and
blood samples were collected for analysis. Complete blood count was performed using an automated haematology
analyser (Mindray®, BC-2800) and CD4
+ T cell count was performed using a flow cytometer (BD FASCount™). Giemsa-
stained blood films were examined to detect malaria parasite. The Pearson’s chi-square, student’s T-test, ANOVA,
and correlation analysis were all performed as part of the statistical analyses.
Results: The prevalence of malaria observed in the study was 7.3 % (95 % CI: 4.8–10.6). No significant association
was observed between the prevalence of malaria and age or gender. The prevalence of malaria was higher in
participants who were not sleeping in insecticide treated bed nets, ITNs (p < 0.001); and in participants who were
not on cotrimoxazole prophylaxis (p = 0.002). The prevalence of malaria (p < 0.001) and malaria parasite density (p =
0.005) were observed to be progressively higher in participants with CD4
+ T cell count below 200cells/μl.
Furthermore, the mean CD4
+ T cell count was observed to be lower in participants coinfected with malaria compared
to non-coinfected participants (323.5 vs 517.7) (p < 0.001). In this study, a negative correlation was observed between
malaria parasite density and CD4
+ T cell count (p = 0.019).
Conclusions: A low prevalence of malaria was observed in the study population. Some of the factors accounting for
the low prevalence of malaria in this study population may include the health seeking habit of PLWHIV, the use of
cotrimoxazole based chemoprophylaxis, and their cautious use of ITNs.
Keywords: Malaria, People living with HIV, Prevalence, Coinfection, CD4
+ T cell count, Cotrimoxazole, ITNs, Cameroon
Background
Although the number of cases and death attributed to
malaria have witnessed a decline recently, the disease is
still responsible for a significant morbidity and mortality
especially in sub-Saharan Africa (SSA) and in children
below 5 years [1]. In 2015, there were 214 million cases
of malaria worldwide, down from the 262 million cases
reported in 2000, and within the same period, the num-
ber of deaths had decreased by 48 % [1]. Malaria is
caused by parasitic protozoan of the genus Plasmodium.
There are five species of Plasmodium which cause dis-
ease in humans namely; Plasmodium ovale, P. vivax, P.
malariae, P. knowlesi and P. falciparum, with the latter
being the most virulent accounting for the majority of
cases and deaths attributed to malaria. As in most parts
of SSA, P. falciparum is the predominant Plasmodium
spp. in Cameroon, accounting for almost 100 % of all
malaria-related cases [2].
SSA is also the region most affected by the HIV pan-
demic. In 2014, there were 25.8 million people living
with HIV in SSA [3], accounting for approximately 70 %
of the global total. Cameroon has one of the highest
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prevalence of HIV in West and Central Africa. In
Cameroon, there were about 600,000 people living with
HIV in 2013 [4]. HIV in Cameroon affects typically the
poor and less privileged [5]. Because HIV is generally
common among the youths, it therefore exerts a nega-
tive impact on the country’s economy (by weakening the
major workforce of the country). The burden of HIV in
Cameroon is also felt in the number of children who are
orphaned by the disease [4, 6].
Malaria and HIV are both common in SSA because all
the factors which favour transmission are present includ-
ing poverty. Due to their overlapping distribution, coin-
fection with malaria and HIV are therefore bound to be
common in the area. Coinfection with malaria and HIV
is thought to have a synergistic effect, with studies
reporting that repeated infection with malaria leads to a
more rapid decline in CD4
+ T cells overtime, meanwhile
malaria coinfection with HIV results in more episodes of
symptomatic malaria [7], and more episodes of severe or
complicated malaria including death in both children
and adults [8–12]. The risk of severe anaemia is also
higher in HIV patients coinfected with malaria com-
pared to HIV patients without malaria [13, 14].
Although the prevalence of coinfection between mal-
aria and HIV had earlier been reported in some parts of
Cameroon [12, 15], there is the need for continuous
monitoring and epidemiologic enquiry to accommodate
the current distribution of malaria which does not seem
to be influenced only by the geographical setting but
also changes overtime with variations in climatic condi-
tions. This study was therefore designed to determine
the prevalence of malaria in people living with HIV
(PLWHIV) in Yaounde, Cameroon, and also to deter-
mine the association between the CD4
+ T cell count and
malaria. This will generate updated baseline data for
clinico-epidemiologic purposes which will improve upon
the management and control of both diseases.
Methods
Study area
This study was performed in Yaounde. Yaounde (3°52′N
11°31′E) with an average elevation of 750 m, is the cap-
ital of Cameroon. With a population of roughly 2.5mil-
lion, Yaounde is second only to Douala as the largest
city in Cameroon [16]. Yaoundé is a very diverse city
with people from different works of life and is home to
most of the administrative structures in the country.
The climate of Yaounde is tropical with 2 rainy (March
to June, September to November) and 2 dry seasons (De-
cember to February, July–August). The temperature here
averages 23.7 °C, and Yaounde receives an average annual
rainfall of 1643 mm [17]. Malaria transmission in Yaounde
is holoendemic and seasonal with Anopheles gambiae as
the main vector [18]. According to hospital records, peak
malaria transmission occurs at the beginning of the rainy
seasons. The prevalence of malaria in the general popula-
tion of Yaounde is estimated at 35 % [19].
Study design and setting
This was a cross-sectional study performed between
April 2015 and June 2016, involving PLWHIV. Partici-
pants were recruited at the Yaounde Military Hospital
(YMH). The YMH is one of the main treatment facility
for HIV/AIDS patients in Yaounde receiving close to a
thousand HIV/AIDS patients every month, coming from
all over Yaounde and it’s environ.
Sample size estimation
Using the following formula for sample size calculation [20];
n ¼ Z
2  p 1−pð Þ
e2
Z = 1.96
p = prevalence of malaria among PLWHIV = 29.4 % [12].
e = error rate = 0.05
n ¼ 1:96
2  0:294 1−0:294ð Þ
0:052
¼ 319
It was estimated that we will require a sample of at
least 319 PLHIV.
Sampling technique
A convenient sampling technique was used, where
PLHIV were consecutively recruited into the study as
they came for consultation or to collect their ARV
drugs.
Study population
PLWHIV were recruited at the HIV treatment center of
the Yaounde Military Hospital. The study population
consisted of HIV/AIDS patients on treatment and newly
diagnosed cases (treatment-naïve). To be included in the
study, participants were to be male or female of all ages.
Participants were not to be on any antimalarial medica-
tion one week prior to the study. Participants were also
required to provide a written informed consent, which
was duly explained to them in English, French or the
local Pidgin English. For minors and those who could
not sign the informed consent, their parents, guardians,
or next of kin did on their behalf.
Sample collection
Once participants gave their informed consent, their
blood samples were collected. About 4 ml of blood was
collected into EDTA anticoagulated test tubes following
aseptic techniques, to perform the complete blood count
Njunda et al. BMC Public Health  (2016) 16:964 Page 2 of 7
(CBC) and CD4
+ T cell count. Thick and thin blood films
were also prepared for malaria microscopy.
Performance of CBC and CD4
+ T cell counts
The CBC was performed using the Mindray® automatic
haematology analyser (BC-2800, Shenzhen Mindray Bio-
Medical Electronics Co., Ltd, Shenzhen, P.R., China).
CD4
+ T cell counts were determined using a flow cyt-
ometer, BD FASCount™.
Detection of malaria parasites
Thick and thin blood films were prepared and stained
with 10 % Giemsa and examined using methods previ-
ously described [21]. Blood films were read by two ex-
pert microscopists who were blinded from the results of
the other. In case of any discrepancy with the results ob-
tained by the two microscopists, a third was brought in
and the results he gave was considered as final. The
thick films were screened for at least 200 fields using the
100X (oil immersion) objective. If asexual parasites were
observed, the density was then determined by counting
the number of parasites against 500 leucocytes. The
slides were only declared negative after counting to
2500WBC. The parasite density was obtained by dividing
the number of parasites by 500 and multiplying the re-
sult by the actual white blood cell count of the patient
obtained from the CBC results [22].
Statistical analysis
Data collected were entered into an Excel spreadsheet and
analysed using the Stata® version 12.1 software (StataCorp
LP, Texas, USA). The statistical tests performed included
the Pearson’s Chi-square for comparison of proportions,
the Student’s T-test and ANOVA for the comparison of
group means, and correlation analysis to determine the as-
sociation between parasite density and CD4
+ T cell count.
Statistical significance was set at p < 0.05.
Results
Four hundred and seven PLWHIV were approached,
355 of them meet the inclusion criteria and were there-
fore enrolled PLWHIV successfully took part into the
study. Among them were 236 (66.5 %) females and 119
(33.5 %) males (Table 1). The ages of the participants
ranged between 5 and 72 (mean ± SD = 35.29 ± 12.26).
The mean duration of HIV was 3.0 ± 3.3 years. A ma-
jority (46.2 %) of the participants had a CD4+ T cell
count above 500cells/μl. A bulk (78.9 %) of the partici-
pants reported to have been using insecticide treated
bed nets (ITNs). Among the participants, 280 (78.9 %)
were on antiretroviral therapy (ART) at enrollment,
and 234 (65.9 %) were on prophylaxis with cotrimoxa-
zole (Table 1).
Twenty six (26) of the 355 PLWHIV were infected
with malaria parasite giving a prevalence of 7.3 % (95 %
CI: 4.8–10.6). The prevalence of malaria was higher in
individuals between 40 and 59years of age (Table 2).
However no significant difference was observed between
the prevalence of malaria and age (p = 0.960). The preva-
lence of malaria was higher in males compared to fe-
males (Table 2). Like the age, no significant association
was observed between prevalence of malaria and gender
in this study (p = 0.388). The prevalence of malaria was
significantly higher in participants that were not sleeping
under ITNs compared to those who were (p <0.001).
The prevalence of malaria was also significantly higher
in participants who were not on prophylaxis with cotri-
moxazole (p = 0.002) (Table 2).
The CD4
+ T cell count of the participants ranged be-
tween 38 and 1600 cells/μl (mean ± SD = 503.5 ± 276.2).
The prevalence of malaria parasitaemia was higher in
participants with CD4
+ T cell count below 200 cells/μl
and lowest in participants with counts above 500cells/μl
(Table 2). A significant association was observed be-
tween prevalence of malaria and CD4
+ T cell count (p <
Table 1 Clinical and demographic characteristics of the study
population
Parameter n (%)





Gender F 236 (66.5)
M 119 (33.5)
Total 355
On HAART Yes 201 (56.6)
No 154 (43.4)
Total 355
Sleeping under ITN Yes 280 (78.9)
No 75 (21.1)
Total 355
Mean (±SD) duration of HIV HAART 4.4 ± 2.5
Naïve 1.2 ± 3.4
Total 3.0 ± 3.3




On prophylaxis with cotrimoxazole Yes 234 (65.9)
No 121 (34.1)
Total 355
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0.001). Furthermore, the mean CD4
+ T cell count was
lower in patients coinfected with malaria parasites com-
pared to non-coinfected participants (323.5 vs 517.7).
The difference in the CD4+ T cell counts between mal-
aria coinfected patients and non-coinfected patients was
observed to be significant statistically (p < 0.001).
The geometric mean parasite density (GMPD) observed
was 1219.7 parasites/μl. The GMPD was progressively
higher in CD4
+ T cell count below 200 cells/μl (Fig. 1). A
Comparison between GMPD and the CD4
+ T cell count
category revealed a significant association (p = 0.005). Fur-
thermore a negative correlation was observed between
CD4
+ T cell count and GMPD (r = −0.465, p = 0.019)
(Fig. 2).
Discussion
Due to the overlapping distribution of malaria and HIV,
coinfection between malaria and HIV are therefore com-
mon in SSA. With the declining trend in the global inci-
dence of malaria [1], it is important to generate updated
data on the burden of malaria in HIV. This study was
aimed at determining the prevalence of malaria in
PLWHIV in Yaounde, as wells as investigate the associ-
ation between CD4+ T cell count and malaria.
In the current study. A prevalence of 7.3 % for malaria
parasite was observed. This prevalence is lower compared
to the prevalence of 34 % for malaria reported in the gen-
eral population of Yaounde [19]. This prevalence is how-
ever higher compared to the 2.24 % reported in PLWHIV
in Bamenda in the Northwest region of Cameroon [15].
Furthermore, the prevalence observed in this study is
lower compared to similar studies performed in other
countries; 11.75 % in Ghana [14], and 18.5 % in Nigeria
[23]. The difference between the prevalence observed in
these studies and ours could be due to the geographical
differences in the study populations and the differences in
the level of malaria endemicity. Malaria in Yaounde can
be described as holoendemic and seasonal [18]. The
prevalence is also very low compared to the prevalence of
malaria in the other high risk groups including children
(where prevalence could be as high as 98 % in some set-
tings) [24], and pregnant women [25]. The low prevalence
of malaria in this group could be attributed to the health
seeking attitude of HIV patients. Studies have shown that
malaria in HIV is more severe [8–13] and patients in-
fected with malaria will quickly go down with the disease
and seek medical attention faster. Another factor that
could be responsible for the low prevalence of malaria
in the target population is the use of cotrimoxazole
(CTX) based chemoprophylaxis which is recommended
for the protection against opportunistic infection in all
PLWHIV in Cameroon. In this study, the prevalence of
malaria among participants who were not on prophy-
laxis with cotrimoxazole was significantly higher than
Table 2 The distribution of malaria parasitaemia with respect to
age, gender, HIV treatment status, CD4+ T cell counts, use of
ITNs and cotrimoxazole prophylaxis
Parameter n (%) Malaria positive
n (%)
χ2 p-value
Age <20 26 2 (7.7) 0.3 0.960
20–39 208 14 (6.7)
40–59 107 9 (8.4)
≥60 14 1 (7.1)
Total 355 26 (7.3)
Gender F 236 15 (6.4) 0.324 0.388*
M 119 11 (9.2)
Total 355 26
On HAART Yes 201 13 (6.5) 0.479 0.540*
No 154 13 (8.4)
Total 355 26
Sleeping under ITN Yes 280 8 (2.9) 39.0 <0.001




<200 40 11 (27.5) 28.5 <0.001
200–499 151 10 (6.6)




Yes 234 10 (4.1) 9.7 0.002
No 121 16 (13.2)
Total 355 26
Fig. 1 Distribution of the GMPD according to the different categories
of CD4
+ T cell count shows a progressively higher GMPD in patients
with CD4
+ T cell count below 200cells/μl (p = 0.005)
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those who were on cotrimoxazole prophylaxis (p =
0.002). Trimethoprim-Sulfamethoxazole which is the
active ingredient of CTX is also effective therapeutically
against malaria [26, 27]. A study performed in
Mozambique had shown that patients that were on
CTX had lower risk of malaria compared to those that
were not on CTX [13]. Regular use of ITNs could also
be responsible for the low prevalence of malaria as evi-
dent from this study that 78.9 % of the patients re-
ported to have been cautiously sleeping in ITNs bearing
in mind their current status. ITNs have been made
available to almost every household in Cameroon thanks
to government efforts to increase coverage and encourage
usage. In this study, the prevalence of malaria was signifi-
cantly (p <0.001) higher in participants that were not
sleeping under ITNs compared to those who were (24 %
vs. 2.9 %), which confirms the benefit of using the ITNs.
This finding is contrary to the study by Njunda et al. [15]
in which no association was observed between the use of
ITNs and prevalence of malaria.
In the current study, no significant association was ob-
served between the prevalence of malaria and age (p =
0.960) or gender (p = 0.388). These findings echo earlier
reports by Njunda et al. [15] and Ojurongbe et al. [23].
The majority of the study participants were adults which
represent a low risk group for malaria unlike children
(especially those below 5 years) who represent the most
at risk group [1]. This may also have accounted for the
low prevalence of malaria in this study. Studies investi-
gating the burden of malaria in HIV-infected children
will be required in the study area to provide a clearer
picture. In the current study, no significant difference
was observed in the prevalence of malaria between
PLWHIV on ART and treatment naïve group (p = 0.540).
This finding is in resonance with the study by Kimbi et
al. [28].
Overall, the mean CD4
+ T cell count observed was
503.5 cells/μl. As recommended by the government,
treatment of HIV/AIDS in Yaounde and Cameroon as a
whole commences at diagnosis and not dependent on
the CD4
+ T cell count as it was before. This may explain
the generally high CD4
+ T cell count of the study popula-
tion. The prevalence of malaria was progressively higher
in patients with CD4
+ T cell count below 200cells/μl (p <
0.001). This is contrary to the study performed by Iroe-
zondu et al. [29]. Furthermore, the CD4
+ T cell count was
significantly lower in HIV patients coinfected with mal-
aria compared to those without, which confirms the
study by Tay et al. [14] in which patients with malaria
were also observed to have lower CD4
+ T cell count. The
finding of a significant association between malaria
prevalence and CD4
+ T cell count is contrary to studies
performed elsewhere [23, 25].
The GMPD observed in this study was 1219 parasites/
μl. The GMPD was also observed to be progressively
higher in patients with CD4
+ T cell count below 200cells/
μl (p = 0.005). This increasing parasite density with de-
creasing CD4
+ T cell count could be attributed to the
weakening of the immune responses of these patients.
Both the cellular and humoral immune responses are
thought to play a role in the protection against malaria
[30], and their activity is regulated by the CD4
+ T cell. A
depletion in the number of CD4
+ T cells will therefore
affect the cellular and humoral immune responses and
Fig. 2 Fitted plot of CD4
+ T cell count against malaria parasite density showing a negative correlation (r = −0.465, p = 0.019)
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consequently the immune responsiveness to malaria an-
tigens [31, 32]. As the immunity weakens, it allows for
the parasites to multiply hence disease progression. The
finding of a significant negative correlation in this study
further supports this hypothesis.
In the current study, only participants who attended
the HIV/AIDS treatment center of the Yaounde Military
Hospital were recruited. This may be biased against
PLWHIV do not attend the facility or who did not come
to the facility within the study timeframe. This may not
give a true representation of PLWHIV in Yaounde. This
serves as a major limitation of the study. In addition, the
study was performed during the rainy season, a period
well known for high malaria transmission. This also,
may have affected the true representation of the preva-
lence of malaria in the study population, as data col-
lected during the dry season may be lower. Studies to
determine how the prevalence of malaria among
PLWHIV varies with respect to season will therefore be
needed in the study area.
Conclusion
A low prevalence of malaria was observed among
PLWHIV in Yaounde, which is lower compared to
prevalence reported in the general population of
Yaounde. The prevalence was also lower compared to
the prevalence reported in other countries in Sub-
Saharan Africa. The low prevalence of malaria could be
attributed to the wide use of insecticide treated bed nets
and the cotrimoxazole based chemoprophylaxis in the
study population. The prevalence of malaria parasit-
aemia was not observed to be associated with age or
gender. The findings of a high prevalence of malaria and
a higher parasite density in participants with CD4
+ T cell
count below 200cells/μl, as well as a negative correlation
between the parasite density and the CD4
+ T cell count is
indicative of the role of the immune response in the pro-
tection against malaria in the target population.
Abbreviations
ART: Antiretroviral therapy; CD: Cluster of differentiation; CTX: Cotrimoxazole;
GMPD: Geometric mean parasite density; HIV: Human Immunodeficiency
Virus; ITN: Insecticide treated bed nets; PLWHIV: People living with HIV;
SSA: Sub-Saharan Africa
Acknowledgement
The authors wish to thank the director, doctors, nurses and laboratory staff
of the Yaounde Military hospital for allowing us to use their patients and for
their help in data collection. Our sincere gratitude also goes to the patients
who took part in this study.
Funding
This study was funded through the departmental research grant of the
department of Medical Laboratory Sciences of the University of Buea.
Availability of data and materials
All the data supporting this findings have been presented in the manuscript.
Authors’ contributions
ALN conceived, designed and coordinated the study, and critically revised
the paper. CN participated in the data collection, took part in the analyses
and interpretation, and conducted the literature search and review. DSN and
JCNA participated in the design of the study and the statistical analysis, and
critically revised the paper. TEK participated in the data collection, took part
in the analyses and interpretation, conducted the literature search and
review, and wrote the first draft of the paper. All authors read and approved
the final paper.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study protocol was approved by the Faculty of Health Sciences
Institutional Review Board (IRB) of the University of Buea, Cameroon. Written
informed consent was obtained from all participants prior to their inclusion.
Author details
1Department of Medical Laboratory Sciences, University of Buea, P.O. Box 63,
Buea, Cameroon. 2Department of Public Health and Hygiene, University of
Buea, P.O. Box 63, Buea, Cameroon.
Received: 19 December 2015 Accepted: 6 September 2016
References
1. World Health Organisation. World malaria report 2015. Geneva: World
Health Organisation; 2015. http://apps.who.int/iris/bitstream/10665/200018/
1/9789241565158_eng.pdf?ua=1. Accessed 17 Dec 2015.
2. World Health Organisation. Cameroon: epidemiological profile. World
malaria report. Geneva: WHO; 2010.
3. UNAIDS. Fact sheet 2015. http://www.unaids.org/sites/default/files/media_
asset/20150901_FactSheet_2015_en.pdf. Accessed 17 Dec 2015.
4. UNAIDS. Cameroon: Epidemiological fact sheet on HIV and AIDS. http://
www.unaids.org/sites/default/files/epidocuments/CMR.pdf. Accessed 17 Dec
2015.
5. Kwenti TE, Nsagha DS, Kwenti BDT, Njunda AL. Sexual risk behaviours
among people living with HIV and implications for control in the north
west region of Cameroon. World Journal of AIDS. 2014;4:198–205.
6. Nsagha DS, Bissek AC, Nsagha SM, Assob JC, Kamga HL, Njamnshi DM, et al.
The burden of orphans and vulnerable children Due to HIV/AIDS in
Cameroon. Open AIDS J. 2012;6:245–58.
7. Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, et al. Effect
of HIV-1 infection on antimalarial treatment outcomes in Uganda: a
population-based study. J Infect Dis. 2006;193(1):9–15.
8. Grimwade K, French N, Mbatha DD, Zungu DD, De-dicoat M, Gilks CF.
Childhood malaria in a region of unstable transmission and high human
immunodeficiency virus prevalence. Pediatr Infect Dis J. 2003;22(12):1057–63.
9. Grimwade K, French N, Mbatha DD, Zungu DD, De-dicoat M, Gilks CF. HIV
infection as a cofactor for severe falciparum malaria in adults living in a
region of unstable malaria transmission in South Africa. AIDS. 2004;18(3):
547–54.
10. Cohen C, Karstaedt A, Frean J, Thomas J, Govender N, Prentice E, et al.
Increased prevalence of severe malaria in HIV-infected adults in South
Africa. Clin Infect Dis. 2005;41(11):1631–7.
11. Otieno RO, Ouma C, Ong’echa JM, Keller CC, Were T, Waindi EN, et al.
Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and
children during acute malaria. AIDS. 2006;20(2):275–80.
12. Nkuo-Akenji T, Tevoufouet EM, Nzang F, Ngufor N, Fon E. High prevalence
of HIV and malaria co-infection in urban Douala, Cameroon. Afr J AIDS Res.
2008;7(2):229–35.
13. Saracino A, Nacarapa EA, da Costa Massinga EA, Martinelli D, Scacchetti M,
de Oliveira C, et al. Prevalence and clinical features of HIV and malaria co-
infection in hospitalized adults in Beira, Mozambique. Malar J. 2012;11:241.
14. Tay SCK, Badu K, Mensah AA, Gbedema SY. The prevalence of malaria
among HIV seropositive individuals and the impact of the co- infection on
their hemoglobin levels. Ann Clin Microbiol Antimicrob. 2015;14:10.
Njunda et al. BMC Public Health  (2016) 16:964 Page 6 of 7
15. Njunda LA, Kamga HLF, Nsagha DS, Assob JCN, Kwenti TE. Low malaria
prevalence in HIV-positive patients in Bamenda, Cameroon. J Microbiol Res.
2012;2(3):56–9.
16. World Gazetteer. Cameroon: largest cities and towns and statistics of their
population. 2013.
17. Climate: Cameroon. http://en.climate-data.org/country/142/#example0.
Accessed 17 Dec 2015.
18. Craig M, Snow R, le Sueur D. A climate-based distribution model of malaria
transmission in sub-Saharan Africa. Parasitol Today. 1999;15(3):105–11.
19. van der Kolk M, Etti Tebo A, Nimpaye H, Ngo Ndombol D, Sauerwein R,
Eling W. Transmission of Plasmodium falciparum in urban Yaoundé
Cameroon is seasonal and age-dependent. Trans R Soc Trop Med and Hyg.
2003;97:375–9.
20. Swinscow TDV, Campbell MJ. Statistics at square. 10th ed. London: BMJ
books; 2002.
21 Njunda AL, Assob NJC, Nsagha SD, Kamga FHL, Mokenyu MD, Kwenti ET.
Comparison of capillary and venous blood using blood film microscopy in
the detection of malaria parasites: A hospital based study. Sci J Microbiol.
2013;2(5):89–94.
22 Research Malaria Microscopy Standards Working Group. Microscopy for the
detection, identification and quantification of malaria parasites on stained
thick and thin films. Geneva: World Health Organization; 2015. p. 25.
23 Ojurongbe O, Oyeniran OA, Alli OAT, Taiwo SS, Ojurongbe TA, et al.
Prevalence of Plasmodium falciparum Parasitaemia and Its Correlation with
Haematological Parameters among HIV-Positive Individuals in Nigeria. J Trop
Med. 2014;161284:6.
24 Njunda AL, Fon SG, Assob JCN, Nsagha DS, Kwenti TDB, Kwenti ET. Malaria
and intestinal parasitic coinfection and their contribution to anaemia in
children in Cameroon. Infect Dis Poverty. 2015;4:43.
25 Johnbull OS, Uche AP, Kesiena AJ, Francis FA, Oyemocho A, Obianwu IM, et
al. Prevalence and risk factors of malaria in HIV-infected pregnant women
on anti-retroviral therapy in Enugu, South East Nigeria. J AIDS Clin Res. 2014;
5:321.
26 Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, et
al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease
morbidity and mortality in HIV-1-infected patients with tuberculosis in
Abidjan, Côte d’Ivoire: a randomised controlled trial. Lancet. 1999;353:1469.
27 Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, et al. Does
cotrimoxazole prophylaxis for the prevention of HIV-associated
opportunistic infections select for resistant pathogens in Kenyan adults? Am
J Trop Med Hyg. 2008;79:320.
28 Kimbi HK, Njoh DT, Ndamukong KJN, Lehman LG. Malaria in HIV/AIDS
Patients at Different CD4+ T Cell Levels in Limbe, Cameroon. J Bacteriol
Parasitol. 2013;4:164.
29 Iroezindu MO, Agaba EI, Okeke EN, Daniyam CA, Obaseki DO, Isa SE, et al.
Prevalence of malaria parasitaemia in adult HIV-infected patients in Jos,
North-central Nigeria. Niger J Med. 2012;21(2):209–13.
30 Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin
Microbiol Rev. 2009;22(1):13–36.
31 Ho M, Webster HK, Looareesuwan S, Supanaranond W, Phillips RE,
Chanthavanich P, et al. Antigen-specific immunosuppression in human
malaria due to Plasmodium falciparum. J Infect Dis. 1986;153:763–71.
32 Hviid L, Theander TG, Abu-Zeid YA, Abdulhadi NH, Jakobsen PH, Saeed BO,
et al. Loss of cellular immune reactivity during acute Plasmodium
falciparum malaria. FEMS Microbiol Immunol. 1991;3:219.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Njunda et al. BMC Public Health  (2016) 16:964 Page 7 of 7
